NKO Partners Advises Dr Max on VIVA Pharm Acquisition
Deal News | Jan 15, 2025 | CEE Legal Matters
NKO Partners has played an instrumental role in advising Dr Max, a leading pharmacy chain, on its strategic acquisition of the VIVA Pharm pharmacy chain, headquartered in Valjevo, Serbia. This acquisition is a continuation of Dr Max's aggressive expansion strategy in Serbia, where they have previously acquired several other pharmacy chains, including Ivancic i Sin, Miletic Plus, Pet-Sar Farm, Melem Pharmacy, Dr Ristic, Uniprom, and many more in recent years. VIVA Pharm consists of 20 retail units spread throughout Serbia, further solidifying Dr Max's footprint in the region. NKO Partners has consistently been the legal adviser to Dr Max over the years, guiding them through multiple acquisitions since 2022, showcasing a robust M&A strategy aimed at consolidating the Serbian pharmaceutical market.
Sectors
- Pharmaceuticals & Healthcare
- Legal Advisory
- Mergers and Acquisitions
Geography
- Serbia – The geographic focus of the article, as all pharmacy acquisitions, including VIVA Pharm, are taking place within Serbia.
Industry
- Pharmaceuticals & Healthcare – This industry is relevant as the article discusses the acquisition of a pharmacy chain by Dr Max, indicating activity in pharmaceutical retailing and healthcare services.
- Legal Advisory – Relevant because NKO Partners, a law firm, plays a prominent role in advising Dr Max on its acquisitions.
- Mergers and Acquisitions – Pertains to the transactional activities and strategic expansion of Dr Max through acquisitions of pharmacy chains.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Dr Max | Acquirer | Company | A leading pharmacy chain engaged in acquiring other pharmacy operations to expand its footprint in Serbia. |
| VIVA Pharm | Target Company | Company | A pharmacy chain headquartered in Valjevo with 20 retail units across Serbia, acquired by Dr Max. |
| NKO Partners | Legal Advisor | Company | A law firm advising Dr Max on various acquisitions, facilitating expansion in the Serbian pharmaceutical market. |